Codex Panel Backs Use Of Observational Data To Support Health Claims
This article was originally published in The Tan Sheet
Executive Summary
Regulatory agencies worldwide should consider all available scientific evidence - including epidemiological and observational studies - when evaluating the basis of health claims for products marketed internationally, a Codex committee recommends
You may also be interested in...
International Panel’s Nutrient Value Guideline May Boost Supplement Exports
Dietary supplement firms soon could export products internationally without having to reformulate to accommodate local nutrient value regulations.
Codex Should Use “Totality Of Evidence” To Validate Science – CRN, IADSA
The International Alliance of Dietary Supplement-Food Associations insists Codex give more weight to observational and epidemiological studies when identifying evidence allowed for scientific substantiation
Industry Speaks Up Against Using EARs To Set Daily Nutrient Values
Dietary supplement industry stakeholders contend an FDA proposal to use estimated average requirements to set daily values for nutrition and supplement facts labels could reduce existing values and lead to lower nutrient levels in food